======= TAF5 ======= == Gene Information == * **Official Symbol**: TAF5 * **Official Name**: TATA-box binding protein associated factor 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6877|6877]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q15542|Q15542]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TAF5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TAF5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601787|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: TAFs are components of the transcription factor IID (TFIID) complex, PCAF histone acetylase complex and TBP-free TAFII complex (TFTC). TAFs components-TIIFD are essential for mediating regulation of RNA polymerase transcription. TAF5/TAFII100 interacts strongly with the histone H4-related TAF6/TAFII80 and the histone H3-related TAF9/TAFII31, as well as a stable complex comprised of both TAF5/TAFII80 and TAF6/TAFII31. Apparently weaker interactions of TAF5/TAFII100 with TBP, TAF1/TAFII250, TAF11/TAFII28, and TAF12/TAFII20, but not TAF7/TAFII55, also have been observed. |TFIID 90kDa| |WD40| |RNA polymerase II general transcription initiation factor activity| |transcription factor TFTC complex| |transcription factor TFIID complex| |histone acetyltransferase activity| |snRNA transcription by RNA polymerase II| |snRNA transcription| |ncRNA transcription| |histone acetylation| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |protein acetylation| |protein dimerization activity| |transcription initiation from RNA polymerase II promoter| |regulation of signal transduction by p53 class mediator| |protein acylation| |DNA-templated transcription, initiation| |actin cytoskeleton| |transcription regulatory region DNA binding| |nuclear chromatin| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |transcription by RNA polymerase II| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |DNA-binding transcription factor activity| |chromatin organization| |viral process| |symbiotic process| |interspecies interaction between organisms| |nucleolus| |peptidyl-amino acid modification| |chromosome organization| |identical protein binding| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |regulation of intracellular signal transduction| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp246|UM0011500 10μM R05 exp246]]|-1.87| |[[:results:exp345|Cidofovir 10μM R07 exp345]]|-1.82| |[[:results:exp148|SB202190 10μM R03 exp148]]|-1.72| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-1.71| |[[:results:exp326|CCT251545 20μM R07 exp326]]|1.83| |[[:results:exp344|Chlorpromazine 10μM R07 exp344]]|1.89| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.409| Global Fraction of Cell Lines Where Essential: 538/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|20/28| |blood|21/28| |bone|20/25| |breast|23/33| |central nervous system|46/56| |cervix|3/4| |colorectal|11/17| |esophagus|8/13| |fibroblast|0/1| |gastric|10/15| |kidney|17/21| |liver|11/20| |lung|52/75| |lymphocyte|13/14| |ovary|22/26| |pancreas|16/24| |peripheral nervous system|8/16| |plasma cell|13/15| |prostate|0/1| |skin|23/24| |soft tissue|5/7| |thyroid|2/2| |upper aerodigestive|14/22| |urinary tract|20/29| |uterus|2/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3018 * **Expression level (log2 read counts)**: 5.43 {{:chemogenomics:nalm6 dist.png?nolink |}}